Meijer Redness Relief

Meijer Redness Relief is an FDA drug label for the active ingredient TETRAHYDROZOLINE HCI manufactured by Meijer Distribution, Inc. administered by OPHTHALMIC. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231222.

Generic: TETRAHYDROZOLINE HCI

Manufacturer: Meijer Distribution, Inc.

Product Type: HUMAN OTC DRUG

Route: OPHTHALMIC

Dosage Form:

NDC: 41250-814

Application: M018

Effective: 20231222

Active Ingredients: Active ingredient Tetrahydrozoline HCI 0.05%

Indications & Usage

Use relieves redness of the eye due to minor eye irritations

Dosage & Administration

Directions instill 1 to 2 drops in the affected eye(s) up to 4 times daily

Contraindications

Not available.

Warnings

Warnings For external use only Ask a doctor before use if you have narrow angle glaucoma When using this product pupils may become enlarged temporarily to avoid contamination, do not touch tip of container to any surface. Replace cap after using. if solution changes color or becomes cloudy, do not use overuse may produce increased redness of the eye remove contact lens before using Stop use and ask a doctor if you experience eye pain changes in vision continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of chlildren. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Adverse Reactions